These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10836400)

  • 1. Mycophenolate mofetil in the prevention of rejection after kidney transplantation.
    Kiehl MG
    Transplantation; 2000 Apr; 69(8):1753-4. PubMed ID: 10836400
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycophenolate mofetil for prevention of acute rejection.
    Winearls CG
    Lancet; 1995 Jul; 346(8969):253-4. PubMed ID: 7616828
    [No Abstract]   [Full Text] [Related]  

  • 3. Mycophenolate Mofetil Study.
    Baltzan M; Shoker A; Baltzan R
    Transplantation; 1997 Jan; 63(1):173-4. PubMed ID: 9000687
    [No Abstract]   [Full Text] [Related]  

  • 4. Mycophenolate mofetil for prevention of acute rejection.
    Moore R; Griffin P; Darby C; Jurewicz A; Lord R
    Lancet; 1995 Jul; 346(8969):253. PubMed ID: 7616827
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mycophenolate mofetil: a new approach by immunosuppressive treatment].
    Thervet E
    Pathol Biol (Paris); 2001 Feb; 49(1):9-11. PubMed ID: 11265229
    [No Abstract]   [Full Text] [Related]  

  • 6. Is mycophenolate mofetil better than azathioprine in organ transplantation?
    Ruggenenti P; Remuzzi G
    Transplantation; 2006 Nov; 82(9):1242-3. PubMed ID: 17102781
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycophenolate mofetil for the transplanted kidney?
    Drug Ther Bull; 1997 May; 35(5):38-40. PubMed ID: 9282420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/pharmacodynamic relationship for mycophenolic acid and suppression of rejection.
    Nicholls AJ
    Clin Biochem; 1998 Jul; 31(5):329-33. PubMed ID: 9721430
    [No Abstract]   [Full Text] [Related]  

  • 9. Mofetil mycophenolate in renal transplantation.
    Pretagostini R; Rossi M; Berloco P; Colonnello M; Bruzzone P; Peritore D; Lonardo MT; Cortesini R
    Transplant Proc; 2001; 33(1-2):1082-3. PubMed ID: 11267200
    [No Abstract]   [Full Text] [Related]  

  • 10. The Tricontinental Mycophenolate Mofetil Trial.
    Browne BJ
    Transplantation; 1996 Dec; 62(11):1697. PubMed ID: 8970635
    [No Abstract]   [Full Text] [Related]  

  • 11. The evolving role of mycophenolate mofetil in renal transplantation.
    Warrens AN
    QJM; 2000 Jan; 93(1):15-20. PubMed ID: 10623777
    [No Abstract]   [Full Text] [Related]  

  • 12. Simultaneous pancreas/kidney transplantation: comparison of mycophenolate mofetil versus azathioprine.
    Elkhammas EA; Yilmaz S; Henry ML; Yenchar J; Bumgardner GL; Pelletier RP; Ferguson RM
    Transplant Proc; 1998 Mar; 30(2):512. PubMed ID: 9532152
    [No Abstract]   [Full Text] [Related]  

  • 13. Mycophenolate mofetil versus azathioprine in organ transplantation.
    Cravedi P; Perna A; Ruggenenti P; Remuzzi G
    Am J Transplant; 2009 Dec; 9(12):2856-7. PubMed ID: 19845579
    [No Abstract]   [Full Text] [Related]  

  • 14. Mycophenolate mofetil, tacrolimus, Neoral: from clinical trials to the clinic.
    Pirsch JD
    Transplant Proc; 1998 Aug; 30(5):2223-5. PubMed ID: 9723448
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of mycophenolate mofetil on the prevention of acute renal allograft rejection.
    Miladipour AH; Ghods AJ; Nejadgashti H
    Transplant Proc; 2002 Sep; 34(6):2089-90. PubMed ID: 12270325
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term benefit of mycophenolate mofetil in renal transplantation.
    Lang P; Pardon A; Audard V
    Transplantation; 2005 Feb; 79(3 Suppl):S47-8. PubMed ID: 15699751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil for the prevention of acute rejection of primary cadaveric kidney transplants: status of the MYC 1866 study at 1 year. The U.S. Mycophenolate Mofetil Study Group.
    Transplant Proc; 1997; 29(1-2):348-9. PubMed ID: 9123033
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycophenolate mofetil in ongoing chronic kidney allograft dysfunction.
    Senn B; Rochat P; Schwarzkopf AK; Weinreich T; Binswanger U
    Transplant Proc; 1998 Dec; 30(8):4075-6. PubMed ID: 9865301
    [No Abstract]   [Full Text] [Related]  

  • 19. Prospective study of mycophenolate mofetil for the prevention of acute rejection in living donor renal allograft recipients.
    Park K; Kim SI; Moon JI; Kim YS; Kim MS
    Transplant Proc; 1998 Nov; 30(7):3575. PubMed ID: 9838565
    [No Abstract]   [Full Text] [Related]  

  • 20. The efficacy of mycophenolate mofetil treatment in the prevention of acute renal rejection is related to plasma level of mycophenolic acid.
    Kuriata-Kordek M; Boratyńska M; Klinger M; Woźniak M; Urbaniak J; Szyber P; Patrzalek D; Tupka D
    Transplant Proc; 2002 Nov; 34(7):2985-7. PubMed ID: 12431678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.